Latest round: IPO. David Veitch is the Chief Executive Officer of Basilea Pharmaceutica, a Swiss commercial-stage biopharmaceutical company specializing.
David Veitch is the Chief Executive Officer of Basilea Pharmaceutica, a Swiss commercial-stage biopharmaceutical company specializing in infectious diseases. He previously served as the Chief Commercial Officer before being named as the successor to the retiring CEO, Ronald Scott.
Full founder directory · Investor directory · Company funding database · Fundraising library